Naprosyn and Post procedural complication - a phase IV clinical study of FDA data

Summary:

Post procedural complication is reported as a side effect among people who take Naprosyn (naproxen), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Post procedural complication when taking Naprosyn. It is created by eHealthMe based on reports of 16,337 people who have side effects when taking Naprosyn from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Post procedural complication?

Post procedural complication is found to be associated with 1,091 drugs and 1,363 conditions by eHealthMe. Check the latest studies of Post procedural complication.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

16,337 people reported to have side effects when taking Naprosyn.
Among them, 38 people (0.23%) have Post procedural complication.

Could Naprosyn cause Post procedural complication?

Among these 38 people:

How long have people been on Naprosyn when they have Post procedural complication? *

What is the gender of people who have Post procedural complication when taking Naprosyn? *

female: 63.16 %
male: 36.84 %

What is the age of people who have Post procedural complication when taking Naprosyn? *

What are other drugs people take besides Naprosyn? *

What are other side effects people have besides Post procedural complication? *

Pneumonia: 10 people, 26.32%
Procedural Pain: 10 people, 26.32%
High Blood Pressure: 9 people, 23.68%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 18.42%
Feeling Abnormal: 7 people, 18.42%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 18.42%
Nausea (feeling of having an urge to vomit): 7 people, 18.42%
Dyspnea (difficult or laboured breathing): 7 people, 18.42%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 7 people, 18.42%
Insomnia (sleeplessness): 6 people, 15.79%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 26.32%
Arthropathy: 5 people, 13.16%
Osteoporosis (bones weak and more likely to break): 5 people, 13.16%
Neck Injury: 5 people, 13.16%
Benign Neoplasm Of Thyroid Gland (benign (non-cancerous) tumours of the thyroid gland): 5 people, 13.16%
Diabetes: 5 people, 13.16%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 7.89%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.89%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 7.89%
Birth Control: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and have Post procedural complication?

- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naprosyn:

Naprosyn (16,738 reports)

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural complication:

Post procedural complication (1,091 drugs)

Browse all the conditions that are associated with Post procedural complication:

Post procedural complication (1,363 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen (the active ingredients of Naprosyn) and Naprosyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.